Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56,047,431
-
Number of holders
-
262
-
Total 13F shares, excl. options
-
47,330,397
-
Shares change
-
+2,243,311
-
Total reported value, excl. options
-
$2,039,414,220
-
Value change
-
+$105,035,296
-
Put/Call ratio
-
64%
-
Number of buys
-
142
-
Number of sells
-
119
-
Price
-
$43.10
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q2 2017
As of 30 Jun 2017 SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) had 306 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 47,330,397 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Invesco Ltd., ACADIAN ASSET MANAGEMENT LLC, Bank of New York Mellon Corp, STATE STREET CORP, RICE HALL JAMES & ASSOCIATES, LLC, DIMENSIONAL FUND ADVISORS LP, ROTHSCHILD ASSET MANAGEMENT INC, and Ranger Investment Management, L.P..
This table shows 306 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.